BOOTHBAY FUND MANAGEMENT, LLC

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 1549230 NEW YORK, NY

Position in VTGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$30,951

-$45,754 QoQ

Shares Held

134,571

0.0% QoQ

Ownership

0.303%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#16

of 48 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $666,641,771 across 159 Biotechnology names. VTGN ranks #146 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	465,787	$87,232,589
2	ABVX	Abivax S.A.	563,367	$75,074,286
3	EXEL	Exelixis, Inc.	804,095	$43,750,808
4	PCVX	Vaxcyte, Inc.	534,163	$31,050,895
5	COGT	Cogent Biosciences, Inc.	692,825	$26,812,327
6	CGEM	Cullinan Therapeutics, Inc.	1,082,611	$19,714,346
7	TNGX	Tango Therapeutics, Inc.	500,497	$15,645,536
8	AVTX	Avalo Therapeutics, Inc.	702,051	$12,973,902

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$30,951	134,571	0.0%	Shares	Other	2026-08-14
2026-03-31	$76,705	134,571	0.0%	Shares	Other	2026-05-15
2025-12-31	$88,816	134,571	-31.7%	Shares	Other	2026-02-17
2025-09-30	$699,435	197,024	+10.8%	Shares	Other	2025-11-14
2025-06-30	$355,716	177,858	0.0%	Shares	Other	2025-08-14
2025-03-31	$444,645	177,858	+693.5%	Shares	Other	2025-05-15
2024-12-31	$66,124	22,415	-52.2%	Shares	Other	2025-02-14
2023-09-30	$245,729	46,895	-38.6%	Shares	Other	2023-11-14
2022-03-31	$94,675	76,351	+66.5%	Shares	Other	2022-05-16
2021-12-31	$89,434	45,864	-20.8%	Shares	Other	2022-02-14
2021-09-30	$158,689	57,916	-54.5%	Shares	Other	2021-11-15
2021-06-30	$401,366	127,418	-57.6%	Shares	Other	2021-08-17
2021-03-31	$640,527	300,717	-35.7%	Shares	Other	2021-05-17
2020-12-31	$906,825	467,436	—	Shares	Other	2021-02-12
No filing history on record for this holder in this stock.